Co-Authors
This is a "connection" page, showing publications co-authored by Jason Trubiano and Natasha Holmes.
Connection Strength
3.437
-
COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2. PLoS One. 2020; 15(12):e0243414.
Score: 0.918
-
Alterations in Smell or Taste-Classic Coronavirus Disease 2019? Clin Infect Dis. 2020 11 19; 71(16):2307-2309.
Score: 0.914
-
Risk factors for readmission following inpatient management of COVID-19 in a low-prevalence setting. Intern Med J. 2021 05; 51(5):821-823.
Score: 0.236
-
Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets. J Clin Immunol. 2021 08; 41(6):1162-1164.
Score: 0.235
-
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. Front Immunol. 2021; 12:646095.
Score: 0.234
-
The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 Jan 25; 1-3.
Score: 0.231
-
The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study. Open Forum Infect Dis. 2018 Dec; 5(12):ofy306.
Score: 0.199
-
Coxiella burnetii endocarditis after Q fever vaccination. J Med Microbiol. 2012 Dec; 61(Pt 12):1775-1779.
Score: 0.129
-
Staff to staff transmission as a driver of healthcare worker infections with COVID-19. Infect Dis Health. 2021 11; 26(4):276-283.
Score: 0.060
-
Identifying patterns in unplanned hospital admissions during the COVID-19 pandemic: a single-centre retrospective study. Intern Med J. 2021 06; 51(6):868-872.
Score: 0.059
-
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
Score: 0.059
-
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
Score: 0.058
-
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection. Pathology. 2020 Dec; 52(7):778-782.
Score: 0.056
-
Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab. Med J Aust. 2018 06 18; 208(11):478-479.
Score: 0.048